G1 Therapeutics (NASDAQ:GTHX) reported its Q1 earnings results on Wednesday, May 3, 2023 at 06:30 AM.
Here’s what investors need to know about the announcement.
Earnings
G1 Therapeutics beat estimated earnings by 17.19%, reporting an EPS of $-0.53 versus an estimate of $-0.64.
Revenue was up $6.04 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 0.82% drop in the share price the next day.
Here’s a look at G1 Therapeutics’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.84 | -0.63 | -1.02 | -0.97 |
| EPS Actual | -0.73 | -0.59 | -0.92 | -1.15 |
| Revenue Estimate | 9.65M | 23.27M | 9.14M | 6.69M |
| Revenue Actual | 10.25M | 23.58M | 10.57M | 6.90M |
To track all earnings releases for G1 Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
